VolitionRX (VNRX) Set to Announce Quarterly Earnings on Tuesday

VolitionRX (NYSEAMERICAN:VNRX) is scheduled to be issuing its quarterly earnings data before the market opens on Tuesday, August 14th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter.

VolitionRX (NYSEAMERICAN:VNRX) last released its quarterly earnings data on Thursday, May 10th. The medical research company reported ($0.17) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.16) by ($0.01).

VolitionRX opened at $1.69 on Friday, MarketBeat.com reports. VolitionRX has a 1 year low of $1.44 and a 1 year high of $4.00.

A number of research analysts have recently weighed in on VNRX shares. Maxim Group started coverage on VolitionRX in a research report on Wednesday, May 16th. They issued a “buy” rating and a $6.00 price target for the company. Benchmark restated a “buy” rating and issued a $5.00 price target (down previously from $7.00) on shares of VolitionRX in a research report on Monday, May 14th.

About VolitionRX

VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers worldwide. The company develops 39 epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. VolitionRX Limited is based in Singapore.

Featured Story: Growth Stocks, What They Are, What They Are Not

Earnings History for VolitionRX (NYSEAMERICAN:VNRX)

Receive News & Ratings for VolitionRX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VolitionRX and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply